C3 and pulmonary arterial hypertension: In studies on chronic hypoxia-induced PAH, C3 deficiency in animal models was associated with reduced pulmonary artery pressure and decreased vascular remodeling, suggesting that C3-driven complement activation exacerbates PAH by promoting immune cell recruitment and inflammation in the pulmonary vasculature [59].